Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-07-25

FDA Approved: TINIDAZOLE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tinidazole from Lupin Pharmaceuticals, Inc., indicating changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tinidazole (tinidazole)

Snippet

SUPPL AP for TINIDAZOLE (TINIDAZOLE)